Advanced Filters
noise

ovulation Clinical Trials

A listing of ovulation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 20 clinical trials
E Engin Türkgeldi, Assoc. Prof

Outcomes of 36 vs 38 Hour Intervals From Ovulation Trigger To Oocyte Pick-Up:A Multi-Center Randomized Controlled Trial

Women who undergo assisted reproduction technology (ART) treatment will be eligible for this study. The goal of this randomized clinical trial is to compare the outcomes of ART treatment between women who have 36 and 38 hours interval between the administration of ovulation trigger (ovulation trigger medication initiates oocyte maturation …

18 - 42 years of age Female Phase N/A
J Jennifer Ka Yee Ko, MBBS

Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome

This is a randomized double-blind controlled trial on the effect of vitamin D supplementation to assess the ovulation rate of women with polycystic ovary syndrome (PCOS) and other reproductive, endocrine and metabolic outcomes after one year of treatment.

18 - 40 years of age Female Phase N/A
A Alisha T Tolani, MD

Sperm Preparation Prior to Intrauterine Insemination Study

This is a randomized controlled trial comparing density gradient centrifugation and microfluidic sperm sorting in patients undergoing intrauterine insemination to evaluate cumulative pregnancy outcomes.

18 - 100 years of age Both Phase N/A
C Claire Webb

Inositol Supplementation to Treat PCOS (INSUPP-PCOS)

To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).

18 - 45 years of age Female Phase 2
A Andrea S. Lukes, MD

Phase II Study of Ovulation in Obese Women

The goal of this clinical trial is to compare the delay in ovulation between placebo to levonorgestrel plus meloxicam in obese women with normal menses. The main questions it aims to answer are: Ovulation will be delayed by ≥7 days following the first dose of levonorgestrel plus meloxicam compared to …

18 - 40 years of age Female Phase 2
P Pinar Ozcan, MD, PhD

Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

The aim of study is to evaluate the results of three different protocols for prevention of premature ovulation in ovarian stimulation cycles. All patients that undergo IVF cycles are randomly divided into three groups. The first group is cetrorelix, the second group is medroxyprogesterone acetate and the third group is …

20 - 38 years of age Female Phase N/A
Y Yesenia Garcia Reyes

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

Girls and women 12-35 years old with obesity and polycystic ovarian syndrome who are on or off metformin, will receive a glucagon like peptide-1 receptor agonist intervention for 10 months to induce metabolic changes, weight loss and improve reproductive abnormalities.

12 - 35 years of age Female Phase 3
A Andrea S. Lukes, MD

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

This clinical trial determines if an oral medication taken within 2 days of anticipated ovulation will delay ovulation by 7 days. The study compares oral placebo tablets (control) to oral levonorgestrel, a synthetic hormone, and meloxicam, a non-steroidal anti-inflammatory drug (treatment) in 21 healthy women between the ages of 18 …

18 - 40 years of age Female Phase 2
D Dimitrios Michalakis, MD

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

The goal of this clinical trial is to compare GnRH-agonist trigger with dual GnRH-agonist and HCG trigger in oocyte donors. The main questions it aims to answer are: Maturation rate (Metaphase II/ Total number of COCs collected) Fertilization rate Embryo quality day 3 Fragmentation rate embryo day 3 Blastulation rate …

20 - 30 years of age Female Phase N/A
M Melissa Gilrain

Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

Adolescent girls with androgen excess have a higher rate of irregular periods and decreased ovulation rates compared to normal girls, and are considered at-risk for developing polycystic ovary syndrome (PCOS). This pilot study will look at whether giving spironolactone might improve ovulation rates in girls with androgen excess, ages 13-19. …

13 - 19 years of age Female Phase N/A

Rewrite in simple language using AI